- Home
- SSL vs LNTH Comparison
SSL vs LNTH Comparison
Compare SSL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- LNTH
- Stock Information
- Founded
- SSL 1950
- LNTH 1956
- Country
- SSL South Africa
- LNTH United States
- Employees
- SSL N/A
- LNTH N/A
- Industry
- SSL Oil & Gas Production
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SSL Energy
- LNTH Health Care
- Exchange
- SSL Nasdaq
- LNTH Nasdaq
- Market Cap
- SSL 4.0B
- LNTH 3.8B
- IPO Year
- SSL N/A
- LNTH 2015
- Fundamental
- Price
- SSL $6.33
- LNTH $57.69
- Analyst Decision
- SSL
- LNTH Buy
- Analyst Count
- SSL 0
- LNTH 6
- Target Price
- SSL N/A
- LNTH $74.50
- AVG Volume (30 Days)
- SSL 1.2M
- LNTH 1.4M
- Earning Date
- SSL 01-01-0001
- LNTH 11-06-2025
- Dividend Yield
- SSL N/A
- LNTH N/A
- EPS Growth
- SSL N/A
- LNTH N/A
- EPS
- SSL 0.59
- LNTH 3.77
- Revenue
- SSL $14,028,282,389.00
- LNTH $1,520,653,000.00
- Revenue This Year
- SSL N/A
- LNTH N/A
- Revenue Next Year
- SSL $5.73
- LNTH $2.25
- P/E Ratio
- SSL $10.48
- LNTH $15.29
- Revenue Growth
- SSL N/A
- LNTH 5.75
- 52 Week Low
- SSL $2.78
- LNTH $47.25
- 52 Week High
- SSL $7.25
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- SSL 54.97
- LNTH 57.91
- Support Level
- SSL $6.06
- LNTH $56.03
- Resistance Level
- SSL $6.65
- LNTH $58.30
- Average True Range (ATR)
- SSL 0.14
- LNTH 1.73
- MACD
- SSL 0.07
- LNTH 0.17
- Stochastic Oscillator
- SSL 77.30
- LNTH 86.00
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: Southern Africa Energy & Chemicals business; and International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Geographically the company generates the majority of its revenue from South Africa.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.